1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis

BACKGROUND: Treatment for people living with HIV (PLWH) and end stage renal disease (ESRD) on hemodialysis (HD) has previously required complex dose-adjusted regimens. We evaluated a daily regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) and established this treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Eron, Joseph J, Wilkin, Aimee, Ramgopal, Moti, Osiyemi, Olayemi, McKellar, Mehri, Slim, Jihad, Asmuth, David, DeJesus, Edwin, German, Polina, Blair, Christiana, Carter, Christoph C, Brainard, Diana M, Collins, Sean E, Martin, Hal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777356/
http://dx.doi.org/10.1093/ofid/ofaa439.1188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777356/
http://dx.doi.org/10.1093/ofid/ofaa439.1188

Ejemplares similares